![Thomas Civik](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 667 877 $ al 30/06/2026
Thomas Civik is Chief Executive Officer & Director at Pyxis Oncology, Inc. since 2026 and Independent Chairman at Imcheck Therapeutics SAS since 2023.
Former roles include President, Chief Executive Officer & Director at Five Prime Therapeutics, Inc. from 2020 to 2021; Independent Chairman at Repare Therapeutics, Inc. from 2021 to 2026; Vice President-Avastin Sales & Marketing at Genentech, Inc. from 2000 to 2017; and Chief Commercial Officer at Foundation Medicine, Inc. from 2017 to 2019.
Education includes undergraduate studies at St. Norbert College, Inc. and an MBA from Kellogg School of Management.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
PYXIS ONCOLOGY, INC. 0,35 % | 20/04/2026 | 221.886 ( 0,35 % ) | 667 877 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PYXIS ONCOLOGY, INC. | Director Ejecutivo | 03/02/2026 |
Imcheck Therapeutics SAS
 Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research | Presidente | 23/03/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
| REPARE THERAPEUTICS INC. | Presidente | 28/01/2026 |
| FIVE PRIME THERAPEUTICS, INC. | Director Ejecutivo | 16/04/2021 |
| FOUNDATION MEDICINE INC | Corporate Officer/Principal | 01/09/2019 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Ventas & Marketing | 01/11/2017 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
St. Norbert College, Inc.
 St. Norbert College, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Foundation Medicine, Inc.
 Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic solutions for cancer care | Health Services |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imcheck Therapeutics SAS
Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research | Health Technology |
Repare Therapeutics, Inc.
 Repare Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of novel cancer therapies | Health Technology |
Pyxis Oncology, Inc.
 Pyxis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical oncology company focused on developing an arsenal of next-generation therapeutics | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
